• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.内源性配体持续激活 PPARα 可增加肝脏脂肪酸氧化,预防 ob/ob 小鼠肥胖。
FASEB J. 2012 Feb;26(2):628-38. doi: 10.1096/fj.11-194019. Epub 2011 Oct 18.
2
Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice.进行性内质网应激导致脂肪酸辅酶 A 氧化酶 1 缺陷型小鼠发生肝癌。
Am J Pathol. 2011 Aug;179(2):703-13. doi: 10.1016/j.ajpath.2011.04.030. Epub 2011 Jun 12.
3
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
4
PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.PPARα基因缺陷的ob/ob肥胖小鼠由于脂肪酸氧化减少而变得更加肥胖,并出现严重的肝脏脂肪变性。
Am J Pathol. 2015 May;185(5):1396-408. doi: 10.1016/j.ajpath.2015.01.018. Epub 2015 Mar 12.
5
Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.去甲二氢愈创木酸通过 PPARα 依赖和非依赖途径改善小鼠代谢失调和肝脏脂质代谢异常。
Am J Physiol Gastrointest Liver Physiol. 2013 Jan 1;304(1):G72-86. doi: 10.1152/ajpgi.00328.2012. Epub 2012 Oct 25.
6
Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.过氧化物酶体增殖物激活受体α和过氧化物酶体脂肪酰辅酶A氧化酶双基因敲除小鼠的过氧化物酶体和线粒体脂肪酸β氧化。基因型与脂肪肝表型的相关性。
J Biol Chem. 1999 Jul 2;274(27):19228-36. doi: 10.1074/jbc.274.27.19228.
7
Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected].人酰基辅酶 A 氧化酶 1b 同工型逆转鼠酰基辅酶 A 氧化酶 1(ACOX1)缺失表型[更正]。
Lab Invest. 2010 May;90(5):696-708. doi: 10.1038/labinvest.2010.46. Epub 2010 Mar 1.
8
Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling.肝脏 ACOX1 通过脂肪组织重塑调节循环脂质水平,从而促进代谢健康。
Nat Commun. 2024 May 17;15(1):4214. doi: 10.1038/s41467-024-48471-2.
9
Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.通过激活肥胖小鼠的过氧化物酶体增殖物激活受体(PPAR)α抑制组织脂质积累来增强胰岛素信号传导。
Med Sci Monit. 2004 Oct;10(10):BR388-95. Epub 2004 Sep 23.
10
Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.肝 X 受体和过氧化物酶体增殖物激活受体 α 的同时激活加剧了高脂肪饮食诱导肥胖小鼠的肝脂肪变性。
PLoS One. 2013 Jun 7;8(6):e65641. doi: 10.1371/journal.pone.0065641. Print 2013.

引用本文的文献

1
Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice.基于油酰乙醇胺的膳食补充剂对饮食诱导的小鼠肥胖的肝脏保护和抗动脉粥样硬化作用
Pathophysiology. 2025 Apr 18;32(2):16. doi: 10.3390/pathophysiology32020016.
2
Transcriptomics and proteomics characterizing the antioxidant mechanisms of semaglutide in diabetic mice with cognitive impairment.转录组学和蛋白质组学表征司美格鲁肽在患有认知障碍的糖尿病小鼠中的抗氧化机制。
Int J Mol Med. 2025 Apr;55(4). doi: 10.3892/ijmm.2025.5497. Epub 2025 Jan 31.
3
Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets.解锁神经精神疾病治疗的新途径:过氧化物酶体增殖物激活受体作为有前途的治疗靶点的新兴潜力。
Psychopharmacology (Berl). 2024 Aug;241(8):1491-1516. doi: 10.1007/s00213-024-06617-6. Epub 2024 May 27.
4
Hepatocyte-Specific PEX16 Abrogation in Mice Leads to Hepatocyte Proliferation, Alteration of Hepatic Lipid Metabolism, and Resistance to High-Fat Diet (HFD)-Induced Hepatic Steatosis and Obesity.小鼠肝细胞特异性PEX16缺失导致肝细胞增殖、肝脏脂质代谢改变以及对高脂饮食(HFD)诱导的肝脂肪变性和肥胖具有抗性。
Biomedicines. 2024 Apr 30;12(5):988. doi: 10.3390/biomedicines12050988.
5
Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD).天然过氧化物酶体增殖物激活受体 γ 激动剂在非酒精性脂肪性肝病(NAFLD)中的治疗作用。
Tissue Barriers. 2024 Jul 2;12(3):2289830. doi: 10.1080/21688370.2023.2289830. Epub 2023 Dec 5.
6
Mapping novel QTL and fine mapping of previously identified QTL associated with glucose tolerance using the collaborative cross mice.利用协作杂交小鼠对新的数量性状基因座进行定位,并对先前鉴定的与葡萄糖耐量相关的数量性状基因座进行精细定位。
Mamm Genome. 2024 Mar;35(1):31-55. doi: 10.1007/s00335-023-10025-0. Epub 2023 Nov 17.
7
Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis.胰岛素抵抗与脂肪组织相互作用是代谢(功能)障碍相关脂肪性肝病发病机制的基础。
World J Gastroenterol. 2023 Jul 7;29(25):3999-4008. doi: 10.3748/wjg.v29.i25.3999.
8
Mouse Models to Study Peroxisomal Functions and Disorders: Overview, Caveats, and Recommendations.研究过氧化物酶体功能和疾病的小鼠模型:概述、注意事项和建议。
Methods Mol Biol. 2023;2643:469-500. doi: 10.1007/978-1-0716-3048-8_34.
9
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy.慢性肝病中的抗氧化剂和抗炎剂:分子机制与治疗
World J Hepatol. 2023 Feb 27;15(2):180-200. doi: 10.4254/wjh.v15.i2.180.
10
ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota.ZJUIDS14通过调节肠道微生物群来减轻小鼠的非酒精性脂肪性肝病。
Front Nutr. 2023 Jan 9;9:1071284. doi: 10.3389/fnut.2022.1071284. eCollection 2022.

本文引用的文献

1
Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice.进行性内质网应激导致脂肪酸辅酶 A 氧化酶 1 缺陷型小鼠发生肝癌。
Am J Pathol. 2011 Aug;179(2):703-13. doi: 10.1016/j.ajpath.2011.04.030. Epub 2011 Jun 12.
2
Human fatty liver disease: old questions and new insights.人类脂肪肝疾病:旧问题与新见解。
Science. 2011 Jun 24;332(6037):1519-23. doi: 10.1126/science.1204265.
3
Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse.转录共激活因子中介亚基 MED1 是小鼠脂肪肝发育所必需的。
Hepatology. 2011 Apr;53(4):1164-74. doi: 10.1002/hep.24155.
4
Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions.通过抑制 klotho 功能来改善葡萄糖代谢和减少肥胖的饮食和遗传证据。
FASEB J. 2011 Jun;25(6):2031-9. doi: 10.1096/fj.10-167056. Epub 2011 Mar 7.
5
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.基于长期增加肝脏脂肪酸氧化的肥胖和糖尿病的分子治疗。
Hepatology. 2011 Mar;53(3):821-32. doi: 10.1002/hep.24140. Epub 2011 Feb 11.
6
Translational pausing ensures membrane targeting and cytoplasmic splicing of XBP1u mRNA.翻译暂停确保了 XBP1u mRNA 的膜靶向和细胞质剪接。
Science. 2011 Feb 4;331(6017):586-9. doi: 10.1126/science.1197142. Epub 2011 Jan 13.
7
Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism.转录因子 Nrf2 调节肝脏脂质代谢中的 SHP 和脂肪生成基因表达。
Am J Physiol Gastrointest Liver Physiol. 2010 Dec;299(6):G1211-21. doi: 10.1152/ajpgi.00322.2010. Epub 2010 Oct 7.
8
The ploidy conveyor of mature hepatocytes as a source of genetic variation.成熟肝细胞的倍性 conveyor 作为遗传变异的来源。
Nature. 2010 Oct 7;467(7316):707-10. doi: 10.1038/nature09414. Epub 2010 Sep 22.
9
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.法尼醇 X 受体通过促进过氧化物酶体增殖物激活受体-γ并干扰 Wnt/β-连环蛋白途径来调节脂肪细胞分化和功能。
J Biol Chem. 2010 Nov 19;285(47):36759-67. doi: 10.1074/jbc.M110.166231. Epub 2010 Sep 17.
10
Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gamma.内质网应激激活的 C/EBP 同源蛋白通过抑制过氧化物酶体增殖物激活受体 γ 增强核因子-κB 信号。
J Biol Chem. 2010 Nov 12;285(46):35330-9. doi: 10.1074/jbc.M110.136259. Epub 2010 Sep 9.

内源性配体持续激活 PPARα 可增加肝脏脂肪酸氧化,预防 ob/ob 小鼠肥胖。

Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.

机构信息

Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

出版信息

FASEB J. 2012 Feb;26(2):628-38. doi: 10.1096/fj.11-194019. Epub 2011 Oct 18.

DOI:10.1096/fj.11-194019
PMID:22009939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3290446/
Abstract

Obesity, a major health concern, results from an imbalance between energy intake and expenditure. Leptin-deficient ob/ob mice are paradigmatic of obesity, resulting from excess energy intake and storage. Mice lacking acyl-CoA oxidase 1 (Acox1), the first enzyme of the peroxisomal fatty acid β-oxidation system, are characterized by increased energy expenditure and a lean body phenotype caused by sustained activation of peroxisome proliferator-activated receptor α (PPARα) by endogenous ligands in liver that remain unmetabolized in the absence of Acox1. We generated ob/ob mice deficient in Acox1 (Acox1(-/-)) to determine how the activation of PPARα by endogenous ligands might affect the obesity of ob/ob mice. In contrast to Acox1(-/-) (14.3±1.2 g at 6 mo) and the Acox1-deficient (ob/ob) double-mutant mice (23.8±4.6 g at 6 mo), the ob/ob mice are severely obese (54.3±3.2 g at 6 mo) and had significantly more (P<0.01) epididymal fat content. The resistance of Acox1(-/-)/ob/ob mice to obesity is due to increased PPARα-mediated up-regulation of genes involved in fatty acid oxidation in liver. Activation of PPARα in Acox1-deficient ob/ob mice also reduces serum glucose and insulin (P<0.05) and improves glucose tolerance and insulin sensitivity. Further, PPARα activation reduces hepatic steatosis and increases hepatocellular regenerative response in Acox1(-/-)/ob/ob mice at a more accelerated pace than in mice lacking only Acox1. However, Acox1(-/-)/ob/ob mice manifest hepatic endoplasmic reticulum (ER) stress and also develop hepatocellular carcinomas (8 of 8 mice) similar to those observed in Acox1(-/-) mice (10 of 10 mice), but unlike in ob/ob (0 of 14 mice) and OB/OB (0 of 6 mice) mice, suggesting that superimposed ER stress and PPARα activation contribute to carcinogenesis in a fatty liver. Finally, absence of Acox1 in ob/ob mice can impart resistance to high-fat diet (60% fat)-induced obesity, and their liver had significantly (P<0.01) more cell proliferation. These studies with Acox1(-/-)/ob/ob mice indicate that sustained activation of lipid-sensing nuclear receptor PPARα attenuates obesity and restores glucose homeostasis by ameliorating insulin resistance but increases the risk for liver cancer development, in part related to excess energy combustion.

摘要

肥胖是一个主要的健康问题,是由能量摄入和消耗之间的失衡引起的。瘦素缺陷型 ob/ob 小鼠是肥胖的典型代表,这是由于能量摄入过多和储存过多所致。缺乏酰基辅酶 A 氧化酶 1(Acox1)的小鼠,该酶是过氧化物酶体脂肪酸β-氧化系统的第一个酶,其特征是能量消耗增加和身体消瘦表型,这是由于内源性配体持续激活过氧化物酶体增殖物激活受体α(PPARα)所致,而在缺乏 Acox1 的情况下,内源性配体未被代谢。我们生成了 Acox1 缺陷型 ob/ob 小鼠(Acox1(-/-)),以确定内源性配体激活 PPARα 如何影响 ob/ob 小鼠的肥胖。与 Acox1(-/-)(6 个月时为 14.3±1.2g)和 Acox1 缺陷型(ob/ob)双突变小鼠(6 个月时为 23.8±4.6g)相比,ob/ob 小鼠严重肥胖(6 个月时为 54.3±3.2g),并且脂肪含量明显更高(P<0.01)。Acox1(-/-)/ob/ob 小鼠对肥胖的抵抗力归因于肝脏中参与脂肪酸氧化的基因的 PPARα 介导的上调增加。在 Acox1 缺陷型 ob/ob 小鼠中激活 PPARα 还降低了血清葡萄糖和胰岛素(P<0.05),并改善了葡萄糖耐量和胰岛素敏感性。此外,PPARα 激活可降低 Acox1(-/-)/ob/ob 小鼠的肝脂肪变性并增加肝细胞再生反应,其速度比仅缺乏 Acox1 的小鼠更快。然而,Acox1(-/-)/ob/ob 小鼠表现出肝内质网(ER)应激,并且还像在 Acox1(-/-)小鼠中观察到的那样(10/10 只)发展为肝细胞癌(8/8 只),但不像在 ob/ob(0/14 只)和 OB/OB(0/6 只)小鼠中那样,这表明 ER 应激和 PPARα 激活的叠加导致脂肪性肝中的癌变。最后,ob/ob 小鼠中缺乏 Acox1 可以抵抗高脂肪饮食(60%脂肪)引起的肥胖,并且它们的肝脏的细胞增殖明显更多(P<0.01)。这些 Acox1(-/-)/ob/ob 小鼠的研究表明,持续激活脂质感知核受体 PPARα 通过改善胰岛素抵抗减轻肥胖并恢复葡萄糖稳态,但增加了肝癌发展的风险,部分原因与过量能量燃烧有关。